SAFETY OF TOPICAL TACROLIMUS OINTMENT FOR PEDIATRIC ATOPIC DERMATITIS PATIENTS

外用他克莫司软膏对小儿特应性皮炎患者的安全性

• 批准号: 6119034
• 负责人: RICHARD GB LANGLEY
• 金额: $ 0.08万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6119034
• 关键词: FK506; atopic dermatitis; child (0-11); clinical research; clinical trial phase I; dosage forms; drug screening /evaluation; human subject; human therapy evaluation; pediatric pharmacology; skin disorder chemotherapy; topical drug application

To evaluate the safety and efficacy of tacrolimus ointment when used continuously or intermittently, for up to one year, in pediatric patients with moderate to severe atopic dermatitis.

评价他克莫司软膏使用时的安全性和有效性 连续或间歇性，长达一年，在儿科 中度至重度特应性皮炎患者。